Table 2.
Patient characteristics of the recurrent rectal tumor
| ReCRT [n = 35] | Long-course CRT [n = 26] | p value | |||
|---|---|---|---|---|---|
| Sex | 0.52 | ||||
| Male | 20 | (57.1) | 17 | (65.4) | |
| Female | 15 | (42.9) | 9 | (34.6) | |
| Age, years (median [IQR]) | 65 | [53–72] | 70 | [64–75] | 0.030 |
| Histology tumor (preoperative) | 0.10 | ||||
| Adenocarcinoma | 26 | (74.3) | 26 | (100.0) | |
| Negative result biopsy | 4 | (11.4) | – | ||
| No biopsy taken | 5 | (14.3) | – | ||
| Location23 | 0.025 | ||||
| Lateral | 12 | (34.3) | 4 | (15.4) | |
| Presacral | 4 | (11.4) | 3 | (11.5) | |
| Anterior | 10 | (28.6) | 2 | (7.7) | |
| Anastomosis | 6 | (17.1) | 13 | (50.0) | |
| Perineum | 3 | (8.6) | 4 | (15.4) | |
| Tumor stage | 0.027 | ||||
| cT1-2N + | 1 | (2.9) | 1 | (3.8) | |
| cT3-4N0 | 28 | (80.0) | 14 | (53.8) | |
| cT3-4N + | 6 | (17.1) | 10 | (38.5) | |
| cTxa N0 | – | 1 | (3.8) | ||
Data are expressed as n (%) unless otherwise specified
CRT chemoradiotherapy, IQR interquartile range
aTumor could not be assessed